Pholcodine (Pholtex Junior, Pholtex Forte)
Pholcodine
Inova Pharmaceuticals (Pty) Ltd
Registration
- Applicant
- Inova Pharmaceuticals (Pty) Ltd
- Certificate holder
- Inova Pharmaceuticals (Pty) Ltd
- Registrations
- 2
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Pholtex junior EACH 5 ml CONTAINS PHOLCODINE 5 mg | 5 mg/5 mlSyrup, | 29001329/10.1/0013Approved 20 May 2022 | Registered | Not determined | PIPIL |
| Pholtex forte EACH 5 ml LIQUID CONTAINS PHOLCODINE 15,0 mg | Not listed | 32011632/10.1/0116 | Cancelled | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
(4R,4AR,7S,7aR,12bS)-3-methyl-9-(2-morpholin-4-ylethoxy)-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-ol
Drag to rotate. Structure from PubChem CID 5311356.
SAHPRA documents
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.